Dermatology Times E-News :
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Dermatology Times E-News
Modern Medicine Network
TOP SEARCHES: Psoriasis // Skin Cancer // Lasers
In this issue
Genes halt cancer
New device detects tumors
SCC recurrence reduced
Dr. Karnik earns NIH award
Rosacea drug study approved
Genta stocks fall
Key Topic Updates

Contact Us
Click here to contact a Dermatology Times editor.

Click here to contact a Dermatology Times sales representative.

Click here to learn about direct mail, reprints and classifieds in Dermatology Times.

Follow us on Twitter

DECEMBER 1, 2009

Genes interact to fight skin cancer
London — Researchers from Cancer Research UK's Cambridge Research Institute say they have found how two genes from the same “family” can interact to stop cancer, reports News-medical.net. More...

New device can ‘see’ otherwise invisible skin tumors
Be’er Sheva, Israel — A new Israeli invention allows cancerous skin tumors to be detected and examined before they become visible to the naked eye, reports news source Haaretz.com. More...
Study: PDT reduces recurrence of SCCs
Minneapolis — Results of a recently completed study appear to establish the efficacy of Levulan Photodynamic Therapy (PDT) in reducing the recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), reports PRNewswire. More...
NIH awards grant for cicatricial alopecia study
Cleveland — The National Institutes of Health has awarded Pratima Karnik, Ph.D., assistant professor of dermatology at Cleveland’s Case Western Reserve University, a grant of $1.77 million to fund a five-year study titled “PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia,” reports the Cicatricial Alopecia Research Foundation (CARF). More...
Sol-Gel gets go-ahead to initiate rosacea treatment studies
Washington — The Food and Drug Administration has acknowledged receipt of Sol-Gel’s Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea, reports Medical News Today. More...
New Jersey pharma firm sees stocks fall
Berkeley Heights, N.J. — Pharmaceutical company Genta Inc., based here, announced recently that a phase 3 drug trial for the melanoma drug Genasense showed no statistically significant benefit compared with a placebo, reports news source Foxbusiness.com. More...
Key Topic Updates
Tools
2009 Laser Guide: Find the ideal device for your practice
Laser Hook-Up: Plug in your parameters to find the right device for your practice
Health Law & Policy
Safety in the workplace: OSHA rules apply in office setting
Don’t be afraid to contact your insurer when you smell a suit at your doorstep
Practice Management
Telephone troubles: Avoid common communication pitfalls
Increase your profits with better coding
Career Opportunities

Advanced Dermatology Associates
Dermatologist FT/PT- New York-Rochester

Avenues Dermatology
Part-Time/Full-Time Dermatologist

Dermatology Associates of Lancaster
BC/BE Dermatologist
Center for Dermatology
Dermatologist
Dermatology & Laser Center of Northern NJ
Dermatologist
Dermatology Associates of Spokane
BC/BE Dermatologist
Lakeside Cosmetic Surgery
BC/BE Dermatologist
Mid Florida Dermatology Associates
Mohs Surgeon
Piedmont Plastic Surgery & Dermatology
Dermatologist
Watson Clinic, LLP
Dermatopathology Opportunity in Florida
Carolinas Dermatology Group, P.A.
General Dermatologist Needed

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.